Quick Takeaways
- Vaddi Krishna filed SCHEDULE 13G/A for Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD).
- Disclosed ownership: 13%.
- Date of event: 31 Dec 2025.
Vaddi Krishna - 31 Dec 2025 SCHEDULE 13G/A Report for Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD)
- Filing Manager
- Vaddi Krishna
- Reporting Manager
- Vaddi Krishna
- Symbol
- PRLD
- Shares outstanding
- 51,297,696 shares
- Disclosed Ownership
- 6,745,647 shares
- Ownership
- 13%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2026, 16:02:12 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Vaddi Krishna disclosed 13% ownership in Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 15 May 2025.
- Current filing was accepted on 13 Feb 2026, 16:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Vaddi Krishna | 13% | 6,745,647 | 6,745,647 | 0 | /s/ Krishna Vaddi | Krishna Vaddi |